Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Sensei Biotherapeutics, Inc. (SNSE) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.57M |
|
-- |
|
-- |
|
$4.85M |
|
$-4.85M |
|
$0.28M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.57M |
|
$-4.85M |
|
$-4.82M |
|
1.26M |
|
1.26M |
|
$-3.62 |
|
$-3.62 |
|
| Balance Sheet Financials | |
$25.79M |
|
$0.11M |
|
$1.80M |
|
$27.59M |
|
$4.44M |
|
-- |
|
$0.15M |
|
$4.58M |
|
$23.01M |
|
$23.01M |
|
$23.01M |
|
1.26M |
|
| Cash Flow Statement Financials | |
$-16.59M |
|
$17.69M |
|
$-0.53M |
|
$9.99M |
|
$10.56M |
|
$0.57M |
|
$0.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.81 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.86% |
|
-19.86% |
|
-16.56% |
|
-19.86% |
|
$18.25 |
|
$-12.97 |
|
$-13.16 |
|